SCHEMBL5754202

SCHEMBL5754202

NC(=O)c1cn[nH]c1-c1cc2ccccc2[nH]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 2/20 0.46
KDR P35968 2/20 0.46
FLT3 P36888 2/20 0.46
AURKA O14965 2/20 0.46
LRRK2 Q5S007 2/20 0.46
PLK4 O00444 1/20 0.46
DAPK3 O43293 1/20 0.46
MAP4K4 O95819 1/20 0.46
CSF1R P07333 1/20 0.46
RET P07949 1/20 0.46
FGFR1 P11362 1/20 0.46
PDGFRA P16234 1/20 0.46
LTK P29376 1/20 0.46
MAP2K2 P36507 1/20 0.46
CSNK1A1 P48729 1/20 0.46
PRKX P51817 1/20 0.46
CDK5 Q00535 1/20 0.46
MAP2K1 Q02750 1/20 0.46
MST1R Q04912 1/20 0.46
PTK2 Q05397 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5756205 0.87 KDM4E (0.47) CHEK1KDRFLT3AURKABRD4
SCHEMBL5755243 0.83 ITK (0.46) AURKABRD4SYKNPC1RAB9A
SCHEMBL5756905 0.83 BRD4 (0.45) AURKABRD4NPC1RAB9AITK
SCHEMBL5752698 0.81 HSP90AA1 (0.55) ROCK1NPC1RAB9AITKTBK1
SCHEMBL5756565 0.80 ITK (0.46) KDRBRD4ITKGSK3BKDM4E
SCHEMBL5756183 0.80 ALDH1A1 (0.48) AURKABRD4NPC1RAB9AITK
SCHEMBL6478196 0.80 KDM4E (0.55) AURKAFGFR1BTKBRD4SYK
SCHEMBL5755157 0.80 DCAF1 (0.45) BRD4ITKGSK3BDCAF1
SCHEMBL5759232 0.78 ITK (0.49) BRD4ITKGSK3BKDM4EHSD17B10
SCHEMBL5755119 0.78 HSP90AA1 (0.57) ROCK1ITKGSK3BKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648884-A2 PYRAZOLYL-INDOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM Pharmacia Italia S.p.A. (IT) 2006-04-26 EP disclosed
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PHARMACIA ITALIA S.P.A. (IT) 2005-02-10 US disclosed
WO-2005005414-A2 PYRAZOLYL-INDOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM PHARMACIA ITALIA S.P.A. (IT) 2005-01-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them MAP3K9, MAP3K20, MAP3K19 CHEK1 242/4885KDR 1419/4885FLT3 388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.